Nagoya, Japan

Susumu Tsustumi


Average Co-Inventor Count = 19.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 3 
 
Institute for Antibodies Co., Ltd.
 patents
silverMedal1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susumu Tsustumi: Innovator in Cancer Treatment

Introduction

Susumu Tsustumi is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of cancer research through his innovative work on antibodies.

Latest Patents

Tsustumi holds a patent for an "Anti-IgSF4 antibody and utilization of the same." This invention aims to clarify a molecule that can serve as a target for treating or diagnosing cancer. The patent focuses on IgSF4, a molecule specifically expressed in lung cancer cells. By treating IgSF4 with an antibody, the antibody-dependent cellular cytotoxicity (ADCC) activity is exerted. This finding positions the anti-IgSF4 antibody as a promising means for effective cancer treatment.

Career Highlights

Throughout his career, Tsustumi has worked with various organizations, including the Institute for Antibodies Co., Ltd. His work has been pivotal in advancing the understanding of cancer treatment methodologies.

Collaborations

Some of his notable coworkers include Yoshikazu Kurosawa and Yasushi Akahori. Their collaborative efforts have contributed to the success of Tsustumi's research and innovations.

Conclusion

Susumu Tsustumi's work in developing the anti-IgSF4 antibody represents a significant advancement in cancer treatment. His innovative approach and collaborations highlight the importance of research in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…